American Journal of Biomedical Research
ISSN (Print): 2328-3947 ISSN (Online): 2328-3955 Website: https://www.sciepub.com/journal/ajbr Editor-in-chief: Hari K. Koul
Open Access
Journal Browser
Go
American Journal of Biomedical Research. 2020, 8(3), 59-62
DOI: 10.12691/ajbr-8-3-1
Open AccessArticle

Have We Passed the Peak? Prevalence and Clinical Presentations of Covid-19 among Sudanese Health Workers

Marwan M Badawi1, , Hazim I El-amin1, Ammar N Mohammed1, Elsiddig H Elfaki1, Tagwa M Badawi2, Marwa M Badawi3 and Abdullah A Othman1

1Laboratory and blood bank Department, Al-Amal Hospital, Khartoum, Sudan

2Department of Parasitology, Faculty of Medical Laboratory Sciences, Omdurman Islamic University, Omdurman, Sudan

3Radiology Department, Al-hammadi Hospital, Riyadh, Saudi Arabia

Pub. Date: September 02, 2020

Cite this paper:
Marwan M Badawi, Hazim I El-amin, Ammar N Mohammed, Elsiddig H Elfaki, Tagwa M Badawi, Marwa M Badawi and Abdullah A Othman. Have We Passed the Peak? Prevalence and Clinical Presentations of Covid-19 among Sudanese Health Workers. American Journal of Biomedical Research. 2020; 8(3):59-62. doi: 10.12691/ajbr-8-3-1

Abstract

Until the 21st of June 2020, more than 1,773,084 worldwide were confirmed cases in the pandemic, among which 111,652 deaths as reported by international health authorities. Majority of patients show a mild presentation of the disease and have good prognosis. The current study was designed to investigate seropositivity of practicing healthcare workers and identify their related clinical symptoms if they found to be seropositive. Known previous positive healthcare workers as well as staff working in isolation wards were excluded. Thirty one healthcare workers were introduced in the study. All participants were firstly screened by Covid-19 ICT screening kits. Covid-19 IgM and IgG antibody levels were further detected using automated CLIA assay for all ICT reactive samples to IgM, IgG or both. Among the 4 participants who were found to be IgM seropositive after screening only 2 (50%) were found to be positive after conducting CLIA assay. Moreover, among the IgG seropositive specimens according to initial screening, 6 (85%) were found to be seropositive after conducting CLIA assay. Eventually, 7 (22%) practicing healthcare workers were found to be exposed to Covid-19 despite of the reactive antibody class as indicated by CLIA assay. Sudan is lacking organized Covid-19 screening programs due to the shortage of testing resources. The current result- although of the low sample size indicated a prevalence of 22% seropositivity among people who look healthy and practice their regular jobs. Taking that under considerations, Covid-19 viral infection prevalence peak might has been passed. Other large-scale studies are appreciated to be approached to better judge the current findings.

Keywords:
Africa Coronavirus healthcare workers Sudan

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17: 181-192.
 
[2]  Zhou P, Yang XL, Wang Xg, hu B, Zhang L, Zhang W, Si hR, Zhu Y, Li B, huang CL, Chen hD, Chen J, Luo Y, guo h, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao gF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270273.
 
[3]  World Health Organization. WHO Situation Report-84 2020 [Available from: https://www.who.int/docs/default- source/coronaviruse/situation-reports/20200527-sitrep-84-covid- 19.pdf?sfvrsn=44f511ab_2.
 
[4]  COVID-19 IgM/IgG Rapid Test. Available online: https://www.biomedomics.com/products/infectiousdisease/covid- 19-rt/ (accessed on 15 June 2020).
 
[5]  Chai X, hu L, Zhang Y, han W, Lu Z, Ke a, Zhou J, Shi g, Fang n, Fan J, Cai J, Fan J, Lan F. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv 2020; 2020.2002.2003.931766.
 
[6]  Liu J, Liu Y, Xiang P, Pu L, Xiong h, Li C, Zhang M, tan J, Xu Y, Song R, Song M, Wang L, Zhang W, han B, Yang L, Wang X, Zhou g, Zhang t, Li B, Wang Y, Chen Z, Wang X. Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 Novel Coronavirus in the early stage. medRxiv 2020; 2020. 2002. 2010. 20021584.
 
[7]  Li, Z, Yi, Y, Luo, X, et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis. J Med Virol. 2020; 1-7.
 
[8]  The World’s First 2019-nCoV CLIA Kits Received CE Mark. Available online: http://www.snibe.com/zh_en/en_newsView.aspx?id=576 (accessed on 15 June 2020).
 
[9]  Yang Y, Yang M, Shen C, Wang F, Yuan J, Li J, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019nCoV infections. MedRxiv 2020: 2020 .02. 11. 20021493.
 
[10]  Boletim Epidemiológico 8. Secretaria de Vigilância em Saúde. Brasília: 2020.
 
[11]  Accelerated Emergency Use Authorization (EUA) Summary Modified Thermo Fisher TaqPath COVID-19 SARS-CoV-2 Test (ORF1ab, N, and S gene detection) (Biocerna). n.d.
 
[12]  He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 2020: 1-4.
 
[13]  Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020: 1-5.
 
[14]  Zhang W, Du RH, Li B, Zheng XS, Yang X Lou, Hu B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020; 9: 386-9.
 
[15]  Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020.
 
[16]  Long, Q., Tang, X., Shi, Q. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med (2020).
 
[17]  The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020 [J]. China CDC Weekly, 2020, 2(8): 113-122.
 
[18]  Erik Greb. Headache May Predict Clinical Evolution of COVID-19. Medscape. June 19, 2020. Available online: https://www.medscape.com/viewarticle/932637 (Accessed on June 20 June, 2020).